|
NEDD4L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.582000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.571200E-01 |
| Normal-vs-Stage2 |
2.504800E-01 |
| Normal-vs-Stage3 |
1.962610E-01 |
| Normal-vs-Stage4 |
3.604400E-01 |
| Stage1-vs-Stage2 |
4.897200E-01 |
| Stage1-vs-Stage3 |
4.177800E-01 |
| Stage1-vs-Stage4 |
6.998800E-01 |
| Stage2-vs-Stage3 |
8.744400E-01 |
| Stage2-vs-Stage4 |
8.247000E-01 |
| Stage3-vs-Stage4 |
9.033000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.214200E-01 |
| Normal-vs-AfricanAmerican |
1.916650E-01 |
| Normal-vs-Asian |
4.189400E-01 |
| Caucasian-vs-AfricanAmerican |
5.199500E-02 |
| Caucasian-vs-Asian |
8.155800E-01 |
| AfricanAmerican-vs-Asian |
7.725800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.801240E-01 |
| Normal-vs-Female |
3.384000E-01 |
| Male-vs-Female |
4.832800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.530200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.288600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.176410E-02 |
| Normal-vs-Age(81-100Yrs) |
9.145400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.497000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.908480E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.128000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.105680E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.609600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.195000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.038200E-01 |
| Classical-VS-Follicular |
4.36839999951033E-07 |
| Classical-VS-Other |
3.793600E-01 |
| Classical-VS-Normal |
9.570200E-01 |
| Tall-VS-Follicular |
4.359600E-03 |
| Tall-VS-Other |
5.256200E-01 |
| Tall-VS-Normal |
4.476200E-01 |
| Follicular-VS-Other |
4.578000E-01 |
| Follicular-VS-Normal |
2.202600E-03 |
| Other-VS-Normal |
4.714000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.728400E-02 |
| Normal-vs-N1 |
5.206000E-01 |
| N0-vs-N1 |
1.920020E-01 |
|
|
